Form 4: Xencor Director Ellen Feigal Reports Equity Compensation and Planned Stock Sale
Insider Trading Report
Xencor Inc. Director Ellen Feigal filed a Form 4 detailing the acquisition of restricted stock units and stock options, alongside a pre-planned sale of common stock.
Summary
- Ellen Feigal, a Director of Xencor Inc. (XNCR), reported changes in her beneficial ownership through a recent SEC Form 4 filing.
- On June 12, 2025, Ms. Feigal acquired 13,686 shares of common stock in the form of restricted stock units (RSUs) at a price of $0, which are scheduled to fully vest on the first anniversary of the grant date.
- Concurrently on June 12, 2025, she was granted stock options to purchase 27,372 shares of common stock at an exercise price of $9.43 per share; these options will vest in equal monthly installments over one year, beginning one month after the grant date, with full vesting by June 12, 2026, and an expiration date of June 11, 2035.
- On June 16, 2025, Ms. Feigal disposed of 2,993 shares of common stock at a price of $9.22 per share, a transaction executed pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2024.
- Following these reported transactions, Ms. Feigal's direct beneficial ownership stands at 19,183 shares of common stock and 27,372 derivative securities (stock options).
Sentiment
Score: 5
Explanation: The filing indicates routine insider transactions, including equity compensation grants and a pre-planned sale of shares. This mix of activity, particularly the 10b5-1 plan, suggests a neutral impact on sentiment, as it reflects standard compensation and liquidity management for a director.
Positives
- Acquisition of 13,686 restricted stock units (RSUs) at $0, representing new equity compensation for the director.
- Grant of stock options for 27,372 shares at an exercise price of $9.43, aligning the director's long-term interests with shareholder value.
Negatives
- Sale of 2,993 shares of common stock at $9.22 per share, which reduces the director's direct common stock holdings.
Future Outlook
The restricted stock units acquired on June 12, 2025, are expected to fully vest on the first anniversary of the grant date. The stock options granted on June 12, 2025, will vest in equal monthly installments over one year, beginning one month after the grant date, with full vesting by June 12, 2026.
Stakeholder Impact
- Shareholders: The grant of equity compensation aligns the director's interests with long-term shareholder value. The sale of shares, while reducing direct ownership, was pre-planned and is a common liquidity event for insiders.
Next Steps
- Vesting of 13,686 restricted stock units on the first anniversary of June 12, 2025.
- Monthly vesting of 27,372 stock options over one year, starting one month after June 12, 2025, with full vesting by June 12, 2026.
Key Dates
| Date | Description |
|---|---|
| February 19, 2025 | Date Power of Attorney was executed by Ellen G. Feigal. |
| June 28, 2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| June 12, 2025 | Date of acquisition of 13,686 restricted stock units and grant of 27,372 stock options. |
| June 16, 2025 | Date of sale of 2,993 shares of common stock. |
| June 12, 2026 | Date by which the 27,372 stock options will be fully vested. |
| June 11, 2035 | Expiration date of the 27,372 stock options. |
Keywords
Xencor Inc., XNCR, SEC Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, Stock Options, 10b5-1 Plan, Director Compensation, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.